Product Description
Mycophenolate mofetil Tablets cyclosporine (Sandimmune, Gengraf, Neoral) and corticosteroids.
Tags: Mycophenolate mofetil Tablets manufacturer, Mycophenolate mofetil Tablets exporter, Mycophenolate mofetil Tablets supplier,Mycophenolate mofetil Tablets, Mycophenolate mofetil potassium, whogmp approved Mycophenolate mofetil potassium tablets manufacturer and supplier, Mycophenolate mofetil Tablets distributor, Mycophenolate mofetil Tablets drop shipper, Mycophenolate mofetil Tablets 500 mg,Mycophenolate mofetil Tablets 500 mg supplier, Mycophenolate mofetil Tablets 500 mg.
ISO/GMP/c-GMP/WHOGMP/ NAFDA Capproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registration of own brand or customer brands inministry of health of clients country and we also provide the products samples, COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country : Saintroy Lifescience export Mycophenolate mofetil Tablets to USA, Canada, Germany, Europe, France,Ghana, Nigeria, Kenya, Senegal, Sudan, UAE, Kuwait, Dubai, Cameroon, Lebanon,Peru, Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore,Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger, Guinea Bissau,Congo, Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua,Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine,Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan,Kazakhstan.
High Standards and Flexible PackagingProduced in GMP and ISO certified plants, our mycophenolate mofetil tablets are manufactured with stringent quality controls. Available in 250 mg and 500 mg strengths, packaging can be customized to meet requirements, typically provided as 10 tablets per strip. Our commitment to regulatory approval guarantees product reliability and safety.
Indications and Clinical BenefitsThese tablets are prescribed to help prevent rejection after kidney, heart, or liver transplants. By inhibiting immune system responses, mycophenolate mofetil reduces the likelihood of graft rejection, promoting long-term transplant success. Regular administration as directed by a healthcare provider supports better outcomes for transplant recipients.
Safe Administration and MonitoringMycophenolate mofetil tablets are for oral use only and must be taken exactly as prescribed by your physician. Close monitoring of blood counts and watching for potential side effects like nausea, diarrhea, or increased infection risk is essential during therapy. Always store this product in a cool, dry place, and keep it away from unauthorized use.
FAQ's of Mycophenolate mofetil Tablets:
Q: How should mycophenolate mofetil tablets be administered?
A: Mycophenolate mofetil tablets are taken orally, usually twice daily, as directed by your healthcare provider. They should be swallowed whole with water and can be taken with or without food. Adhering closely to the prescribed schedule enhances efficacy in preventing transplant rejection.
Q: What are the key precautions when using mycophenolate mofetil tablets?
A: It is important to monitor your blood counts regularly while taking this medication, as it can cause leukopenia and increase susceptibility to infections. Inform your healthcare professional immediately if you experience persistent diarrhea, fever, or other unusual symptoms.
Q: When is mycophenolate mofetil indicated for use?
A: Mycophenolate mofetil is indicated for the prevention of organ rejection in patients who have undergone kidney, heart, or liver transplants. It is part of immunosuppressive therapy prescribed to reduce the risk that your immune system will attack the transplanted organ.
Q: Where are these tablets manufactured and how is quality ensured?
A: The tablets are produced in GMP and ISO-certified manufacturing facilities in India. Quality assurance is maintained at every step, and products are approved by regulatory bodies such as the FDA, EMA, or relevant local authorities before export or distribution.
Q: What are the main side effects associated with mycophenolate mofetil?
A: Common side effects include nausea, diarrhea, leukopenia (a decrease in white blood cells), and an increased risk of infections. Always discuss side effects with your doctor, especially if they are persistent or severe.
Q: How does mycophenolate mofetil benefit transplant patients?
A: By suppressing the immune response, mycophenolate mofetil plays a crucial role in preventing the rejection of transplanted organs. This promotes better graft survival, enhances patient quality of life, and improves the long-term success rate of organ transplantation.
Q: What is the proper storage process for mycophenolate mofetil tablets?
A: Store the tablets in a cool and dry place, away from direct sunlight and out of reach of children. Proper storage helps maintain their effectiveness and ensures the medication remains safe for use throughout its two-year shelf life.